• Mon, January 6, 2020
  • Thu, January 2, 2020
  • Fri, January 3, 2020

Randall Stanicky Maintained (AMRX) at Hold with Increased Target to $4 on, Jan 2nd, 2020

Randall Stanicky of RBC Capital, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Increased Target from $3 to $4 on, Jan 2nd, 2020.

Randall has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $4 on, Monday, November 11th, 2019